Lipid lowering with inclisiran: a real-world single-centre experience.

Pritpal PadamLucy BartonStewart WilsonAlessia DavidShahenaz WaljiFerruccio de LorenzoKausik K RayBen JonesJaimini Cegla

Published in: Open heart (2023)

Inclisiran use in line with National Institute for Health and Care Excellence guidelines led to significant lowering of LDL-c at 2 months, with efficacy similar to that reported in trials with good tolerability.

Keyphrases

healthcare
quality improvement
public health
palliative care
open label
mental health
health information
fatty acid
pain management
health promotion
affordable care act
double blind
low density lipoprotein
placebo controlled
climate change